DK665688A - Polypeptid - Google Patents
PolypeptidInfo
- Publication number
- DK665688A DK665688A DK665688A DK665688A DK665688A DK 665688 A DK665688 A DK 665688A DK 665688 A DK665688 A DK 665688A DK 665688 A DK665688 A DK 665688A DK 665688 A DK665688 A DK 665688A
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptide
- expressed
- recombinant yeast
- immunogenic polypeptide
- vivax circumsporozoite
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 240000009188 Phyllostachys vivax Species 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/032,327 US4826957A (en) | 1985-07-12 | 1987-03-30 | Immunogenic recombinant yeast expression product and method for purifying it |
| PCT/US1988/001151 WO1988007550A1 (en) | 1987-03-30 | 1988-03-30 | Immunogenic recombinant yeast expression product and method for purifying it |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK665688D0 DK665688D0 (da) | 1988-11-29 |
| DK665688A true DK665688A (da) | 1989-01-30 |
Family
ID=21864347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK665688A DK665688A (da) | 1987-03-30 | 1988-11-29 | Polypeptid |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4826957A (es) |
| EP (1) | EP0307472B1 (es) |
| JP (1) | JPH01503517A (es) |
| AT (1) | ATE81136T1 (es) |
| AU (1) | AU615451B2 (es) |
| DE (1) | DE3875043T2 (es) |
| DK (1) | DK665688A (es) |
| ES (1) | ES2009588A6 (es) |
| HK (1) | HK112693A (es) |
| IL (1) | IL85906A0 (es) |
| NZ (1) | NZ224088A (es) |
| PH (1) | PH27079A (es) |
| WO (1) | WO1988007550A1 (es) |
| ZA (1) | ZA882269B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0229829B1 (en) * | 1985-07-12 | 1995-02-22 | New York University | Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein |
| IL85905A0 (en) * | 1987-03-30 | 1988-09-30 | Univ New York | Immunogenic recombinant yeast expression product and method for purifying it |
| US4997647A (en) * | 1987-03-30 | 1991-03-05 | New York University | Vaccine against the sporozoite stage of malaria |
| US5853739A (en) * | 1988-05-02 | 1998-12-29 | The United States Of America As Represented By The Department Of Health And Human Services | Transmission-blocking vaccine against malaria |
| GB8812214D0 (en) * | 1988-05-24 | 1988-06-29 | Hoffmann La Roche | Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope |
| NZ237827A (en) * | 1990-04-16 | 1994-03-25 | Strohtech Inc | Pure globin chain or haem-binding fragment thereof and methods for its production |
| US5095093A (en) * | 1990-11-06 | 1992-03-10 | The United States Of America As Represented By The Secretary Of The Navy | Protective four amino acid epitope against Plasmodium vivax malaria |
| AU1588092A (en) | 1991-02-22 | 1992-09-15 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Transmission blocking vaccine against malaria |
| WO1993011157A1 (en) * | 1991-11-27 | 1993-06-10 | The Council Of The Queensland Institute Of Medical Research | MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX) |
| US8206749B1 (en) | 1999-02-26 | 2012-06-26 | Novartis Vaccines And Diagnostics, Inc. | Microemulsions with adsorbed macromolecules and microparticles |
| US6737262B1 (en) * | 2000-07-11 | 2004-05-18 | Robert I. Bolla | Animal feed containing polypeptides |
| CA2593643C (en) | 2005-01-18 | 2016-03-22 | Walter Reed Army Institute Of Research | A plasmodium vivax hybrid circumsporozoite protein and vaccine |
| US9364525B2 (en) * | 2006-07-18 | 2016-06-14 | Glaxosmithkline Biologicals Sa | Vaccines for malaria |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4466917A (en) * | 1981-02-12 | 1984-08-21 | New York University | Malaria vaccine |
| EP0175261B1 (en) * | 1984-09-12 | 1991-12-11 | Chiron Corporation | Hybrid particle immunogens |
| EP0229829B1 (en) * | 1985-07-12 | 1995-02-22 | New York University | Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein |
| IL85905A0 (en) * | 1987-03-30 | 1988-09-30 | Univ New York | Immunogenic recombinant yeast expression product and method for purifying it |
-
1987
- 1987-03-30 US US07/032,327 patent/US4826957A/en not_active Expired - Fee Related
-
1988
- 1988-03-29 IL IL85906A patent/IL85906A0/xx unknown
- 1988-03-30 NZ NZ224088A patent/NZ224088A/en unknown
- 1988-03-30 PH PH36721A patent/PH27079A/en unknown
- 1988-03-30 EP EP88904772A patent/EP0307472B1/en not_active Expired - Lifetime
- 1988-03-30 DE DE8888904772T patent/DE3875043T2/de not_active Expired - Fee Related
- 1988-03-30 ES ES8801014A patent/ES2009588A6/es not_active Expired
- 1988-03-30 JP JP63504552A patent/JPH01503517A/ja active Pending
- 1988-03-30 WO PCT/US1988/001151 patent/WO1988007550A1/en active IP Right Grant
- 1988-03-30 AT AT88904772T patent/ATE81136T1/de not_active IP Right Cessation
- 1988-03-30 AU AU17914/88A patent/AU615451B2/en not_active Ceased
- 1988-03-30 ZA ZA882269A patent/ZA882269B/xx unknown
- 1988-11-29 DK DK665688A patent/DK665688A/da not_active Application Discontinuation
-
1993
- 1993-10-21 HK HK1126/93A patent/HK112693A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0307472B1 (en) | 1992-09-30 |
| HK112693A (en) | 1993-10-29 |
| PH27079A (en) | 1993-02-01 |
| DE3875043D1 (de) | 1992-11-05 |
| JPH01503517A (ja) | 1989-11-30 |
| AU1791488A (en) | 1988-11-02 |
| ZA882269B (en) | 1988-09-22 |
| DK665688D0 (da) | 1988-11-29 |
| WO1988007550A1 (en) | 1988-10-06 |
| IL85906A0 (en) | 1988-09-30 |
| ES2009588A6 (es) | 1989-10-01 |
| ATE81136T1 (de) | 1992-10-15 |
| US4826957A (en) | 1989-05-02 |
| AU615451B2 (en) | 1991-10-03 |
| EP0307472A4 (en) | 1989-06-27 |
| EP0307472A1 (en) | 1989-03-22 |
| NZ224088A (en) | 1990-12-21 |
| DE3875043T2 (de) | 1993-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATA257190A (de) | Virales polypeptid | |
| DK665688A (da) | Polypeptid | |
| AU575588B2 (en) | Extraction of human-y interferon of 18 kdalton using the protease inhibitor guanidine-hcp | |
| NO864139D0 (no) | Polypeptid virksomt ved dannelse av aids-antistoff. | |
| NO892251D0 (no) | Fremgangsmaate ved fremstilling av kokkoidosevaksine ved rekombinante teknikker. | |
| DK603888D0 (da) | Rekombinant virus | |
| ES536027A0 (es) | Un procedimiento para la produccion de un polipeptido | |
| FR2620459B1 (fr) | Virus recombinant de la vaccine | |
| DK162890D0 (da) | Polypeptid | |
| DE69327553D1 (de) | E.Coli P-Fimbriae als immunogener Träger gegen GnRH | |
| SE8503228D0 (sv) | Ny beta-urogastron-gen | |
| DK354389D0 (da) | Polypeptid | |
| AU8260991A (en) | Malaria vaccine comprising an immunogenic polypeptide | |
| DE68918712D1 (de) | Rekombinante Eimeria tenella-Vakzine. | |
| DE3886517D1 (de) | Menschlicher Prourokinase ähnliches Polypeptid. | |
| AU1092588A (en) | Expression of the p. falciparum circumsporozoite protein by yeast | |
| PT87137A (pt) | Process for the preparation of an immunogenic polypeptide express by a recombinant yeast | |
| DE3853743D1 (de) | Rekombinanter menschlicher ADF. | |
| ATA264487A (de) | Homogene, rekombinante immun-interferonfragmente | |
| IT1262898B (it) | Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk | |
| NZ335929A (en) | Use of a recombinant polypeptide having a glycosyl-phosphatidylinositol anchor for inducing an immune response | |
| DK494189D0 (da) | Polypeptid | |
| DE3890354T1 (de) | Synthetisches polypeptid mit grippevirus-antigenreaktivitaet | |
| ATE98990T1 (de) | Menschlicher prourokinase aehnliches polypeptid. | |
| DK236190D0 (da) | Polypeptid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |